Federal Register / Vol. 74, No. 142 / Monday, July 27, 2009 / Notices 37039 

Cancer Statistics (USCS), which CDC 

has published annually since 2002. The 

latest USCS report published in 2009 

provided cancer statistics for 96% of the 

United States population from all cancer 

registries whose data met national data 

standards. Prior to the publication of 

USCS, cancer incidence data at the 

national level were available for only 

14% of the population of the United 

States. 

The NPCR CSS also allows CDC to 

monitor cancer trends over time, 

describe geographic variation in cancer 

incidence throughout the country, and 

provide incidence data on minority 

populations and rare cancers. These 

activities and analyses further support 

CDC’s planning and evaluation efforts 

for state and national cancer control and 

prevention. In addition, datasets can be 

made available for secondary analysis. 

Each responding CCR is asked to 

report a cumulative file containing 

incidence data from the first diagnosis 

year for which the cancer registry 

collected data with the assistance of 

NPCR funds (e.g., 1995) through 12 

months past the close of the most recent 

diagnosis year (e.g., 2007). Because 

cancer incidence data are already 

collected and aggregated at the state 

level the additional burden of reporting 

the information to CDC is small. 

Information is transmitted to CDC 

electronically once per year. 

The Revision request will include 

changes. First, data definitions will be 

updated to reflect changes in national 

standards for cancer diagnosis and 

coding. In addition, the number of 

respondents will decrease. Respondents 

will be 45 stated-based CCRs, the CCR 

of the District of Columbia, the CCR of 

Puerto Rico, and the CCR that aggregates 

information from 10 flag territories and 

freely associated states in the Pacific 

Islands. In the previous OMB approval 

period, the territories, commonwealths, 

or freely-associated states were counted 

as individual respondents. In the next 

OMB approval period, the 10 flag 

territories, commonwealths, and freelyassociated states will be counted as one 

respondent to more accurately reflect 

funding, operations and actual response 

burden. States that receive sole funding 

from the National Cancer Institute are 

not included as respondents. The 

adjusted number of respondents will 

result in a reduction in the total 

estimated burden hours for the NPCR 

CSS. The estimated burden per response 

will not change. 

There are no costs to respondents 

except their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

Central Cancer Registries in States, Territories, and the District of Columbia 48 1 2 96 

Dated: July 17, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–17781 Filed 7–24–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Clinical Trial Planning 

Grant. 

Date: August 13, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817 

(Telephone Conference Call). 

Contact Person: Kenneth E. Santora, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIH/NIAID/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892–7616, 301– 

496–2550, ks216i@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: July 21, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17833 Filed 7–24–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; NIAAA–NOT–OD–09–058 

Competitive Revision Supplement. 

Date: July 29–August 3, 2009. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 


jlentini on DSKJ8SOYB1PROD with NOTICES
37040 Federal Register / Vol. 74, No. 142 / Monday, July 27, 2009 / Notices 

Contact Person: Ranga Srinivas, PhD, 

Chief, Extramural Project Review Branch, 

Office of Extramural Activities, National 

Institutes of Health, National Institute on 

Alcohol Abuse & Alcoholism, 5635 Fishers 

Lane, Room 2085, Rockville, MD 20852. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: July 20, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17731 Filed 7–24–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Grand Opportunities—Unsolicited 

Topics (ARRA). 

Date: August 5–6, 2009. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Pier 5 Hotel, 711 Eastern Avenue, 

Baltimore, MD 21202. 

Contact Person: Shelley S. Sehnert, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7206, 

Bethesda, MD 20892–7924. 301–435–0303. 

ssehnert@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Grand Opportunities in BioResource 

Program (ARRA). 

Date: August 7, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Columbia Hotel, 10207 

Wincopin Circle, Columbia, MD 21044. 

Contact Person: David A. Wilson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7204, 

Bethesda, MD 20892–7924. 301–435–0299. 

wilsonda2@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research; 93.701, ARRA 

Related Biomedical Research and Research 

Support Awards, National Institutes of 

Health, HHS) 

Dated: July 20, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17734 Filed 7–24–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Capacity Building 

Assistance (CBA) To Improve the 

Delivery and Effectiveness of Human 

Immunodeficiency Virus (HIV) 

Prevention Services for High-Risk and/ 

or Racial/Ethnicity Minority 

Populations, Program Announcement 

Number PS09–906, Initial Review 

Location: Doubletree Hotel AtlantaBuckhead, 3342 Peachtree Road, NE., 

Atlanta, Georgia 30326. Telephone: 

(404) 231–1234. 

Correction: This notice was published 

in the Federal Register on July 13, 2009, 

Volume 74, Number 132, page 33450. 

The original notice was published with 

an incorrect location. 

Contact Person for More Information: 

Monica Farmer, M.Ed., Public Health 

Analyst, Strategic Science and Program 

Unit, Office of the Director, 

Coordinating Center for Infectious 

Diseases, CDC, 1600 Clifton Road NE., 

Mailstop E–60, Atlanta, GA 30333. 

Telephone (404) 498–2277. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: July 20, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office Centers for Disease Control and 

Prevention. 

[FR Doc. E9–17796 Filed 7–24–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Center of Excellence 

in Public Health Informatics, Request 

for Application (RFA), HK–09–001, 

Initial Review 

Location: Doubletree Hotel AtlantaBuckhead, 3342 Peachtree Road, NE., 

Atlanta, Georgia 30326. Telephone: 

(404) 231–1234. 

Correction: This notice was published 

in the Federal Register on July 1, 2009, 

Volume 74, Number 125, page 31452. 

The original notice was published with 

an incorrect location. 

CONTACT PERSON FOR MORE INFORMATION: 

Scott J.N. McNabb, PhD, M.S., Associate 

Director for Science, National Center for 

Public Health Information and Service, 

CDC, 1600 Clifton Road NE., Mailstop 

E–78, Atlanta, GA 30333. Telephone 

(404) 498–6427. E-mail 

smcnabb@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: July 20, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–17799 Filed 7–24–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 


jlentini on DSKJ8SOYB1PROD with NOTICES